BORGIA, GUGLIELMO
 Distribuzione geografica
Continente #
NA - Nord America 3.436
EU - Europa 1.659
AS - Asia 1.309
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 1
Totale 6.469
Nazione #
US - Stati Uniti d'America 3.294
SG - Singapore 706
IT - Italia 607
CN - Cina 564
NL - Olanda 291
FI - Finlandia 196
IE - Irlanda 169
DE - Germania 149
CA - Canada 140
UA - Ucraina 94
CI - Costa d'Avorio 50
GB - Regno Unito 49
SE - Svezia 42
FR - Francia 20
CH - Svizzera 18
IN - India 16
CZ - Repubblica Ceca 9
EG - Egitto 8
TR - Turchia 7
IR - Iran 4
EU - Europa 3
RS - Serbia 3
VN - Vietnam 3
BE - Belgio 2
BG - Bulgaria 2
BR - Brasile 2
LU - Lussemburgo 2
MX - Messico 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CL - Cile 1
ES - Italia 1
HK - Hong Kong 1
ID - Indonesia 1
JP - Giappone 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MK - Macedonia 1
RO - Romania 1
RU - Federazione Russa 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 6.469
Città #
Chandler 606
Singapore 601
Amsterdam 282
Millbury 282
Princeton 198
Nanjing 188
Naples 173
Santa Clara 165
Ottawa 136
Jacksonville 114
Napoli 104
Ashburn 103
Beijing 90
Boston 90
Des Moines 85
Wilmington 69
Nanchang 64
Boardman 50
Hebei 40
Jiaxing 38
Shenyang 34
Ann Arbor 33
Krefeld 31
Woodbridge 31
Lawrence 28
Houston 27
Tianjin 27
Norwalk 21
Changsha 18
Basel 17
Indiana 14
Los Angeles 13
Seattle 12
Falls Church 11
Caserta 10
Helsinki 10
Hangzhou 8
Pomigliano D'arco 8
Boise 7
Brno 7
Dallas 7
Dublin 7
Kunming 7
Mugnano di Napoli 7
Munich 7
Washington 7
Changchun 6
Kronberg 6
Orange 6
Redmond 6
Fisciano 5
Jinan 5
New York 5
Pune 5
Bologna 4
Brescia 4
Cairo 4
Castellammare di Stabia 4
Acerra 3
Agropoli 3
Bari 3
Campagna 3
Cercola 3
Chicago 3
Dung 3
Edinburgh 3
Florence 3
Guangzhou 3
Lanzhou 3
Marseille 3
Milan 3
Mumbai 3
Palermo 3
Redwood City 3
Richland 3
Rome 3
Shanghai 3
Shenzhen 3
Zhengzhou 3
Acquaviva Delle Fonti 2
Augusta 2
Chandigarh 2
Chions 2
Cirò 2
Cologno Monzese 2
Espoo 2
Fremont 2
Gualtieri 2
Lappeenranta 2
Lizzanello 2
Maricopa 2
Marigliano 2
Mountain View 2
Olomouc 2
Pozzuoli 2
Prineville 2
Richmond 2
San Prisco 2
Sandston 2
Sennori 2
Totale 4.052
Nome #
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 132
Hemolytic anemia during pegylated interferon alpha 2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. A case report 77
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 65
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 64
CpG and Toll-like receptor 9 in primary biliary cirrhosis: a possible intracellular interaction from virus exposure? 62
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 59
CD4+ T lymphocytes and cryoglobulins in patients coinfected with HIV and hepatitis C virus: forgetting the hidden CD4+ cell subsets. 57
HIV and hepatitis C virus: facts and controversies 57
A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital 55
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 55
Human Platelet Antigen Genotypes As Predictors of Liver Cirrhosis In Patients With Hcv Chronic Infection 54
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 52
Asunaprevir for hepatitis C: A safety evaluation 52
A SIMPLE NONINVASIVE SCORE PREDICTS GASTROESOPHAGEAL VARICES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS. 51
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 51
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 50
Human Platelet Antigen 3 Genotype Is An Independent Predictor of Platelet Count In Patients With Chronic Hepatitis C 48
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir 48
Does compulsory vaccination limit personal freedom? Ethical issues 48
Rara e grave manifestazione dell’infezione da HHV-6: la sindrome DRESS. 47
Human immunodeficiency virus and subtype 1B hepatitis C virus: more similarities than differences in T-helper subsets. 45
HCV and GBV-c/HGV infection in HIV positive patients in southern Italy. 45
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 45
Specific immunoglobulin against HCV: new perspectives. 44
Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection 44
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 44
Prevalenza di infezioni da CMV, HHV-6 o EBV in bambini con disturbi dello spettro autistico. 43
ABT-450: A novel protease inhibitor for the treatment of hepatitis C virus infection 43
Antibiotic prophylaxis and risk of infections in thyroid surgery: Results from a national study (UEC - Italian Endocrine Surgery Units Association) 42
TNF-alpha serum level elevations in chronic hepatitis C patients with diabetes mellitus. 41
Blood letting therapy in HCV-related iron overload - Part 1: Evaluation of clinical, hematological and hepatic parameters 41
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 41
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 40
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 40
Current evidence on the management of hepatitis B in pregnancy 40
Blood In Saliva of Patients With Acquired-immunodeficiency-syndrome - Possible Implication In Sexual Transmission of the Disease 40
Human platelet antigen 3 genotype predicts platelet count in patients with HCV infection 40
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 40
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 40
Beclabuvir for the treatment of hepatitis C 40
Studio sulla conoscenza dell’antibioticoterapia tra i medici di un ospedale universitario di terzo livello 40
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 40
Febbre di origine sconosciuta (FUO): nostra casistica 39
Human immunodeficiency virus per se exerts atherogenic effects. 39
The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus. 39
Blood letting therapy in HCV-related iron overload - Part 2: Evaluation of HFE genetic mutation, HCV genotype and viral load 39
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 39
Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human Fc epsilon RI+ cells through interaction with the kappa light chain of IgE 38
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 38
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 38
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 38
Direct acting antiviral agents and hepatocellular carcinoma development: Don't take it for granted 38
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 38
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 38
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. 37
A CASE OF PEGYLATED INTERFERON ALPHA-RELATED DIABETIC KETOACIDOSIS: CAN THIS COMPLICATION BE AVOIDED? 37
Mutante lamivudino-resistente in paziente in profilassi con lamivudina in corso di chemioterapia antiblastica per linfoma non-Hodgkin: recupero clinico con terapia di associazione lamivudina e adefovir. 37
Blood in saliva of HIV seropositive drug abusers: possible implication in AIDS transmission. 37
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. 37
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 37
A pill a day keeps HCV away 37
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 37
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 37
Aetiological association of virus like particles with hepatitis C. 36
Detection of Hepatitis-c Virus-rna By Polymerase Chain-reaction In Dental Surgeries 36
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 36
Compromissione cognitiva subclinica in pazienti HCV-positivi 35
[Effect of cocaine administration on experimental hepatitis in the mouse caused by MHV-3 virus: preliminary results]. 35
Prevalence of circulating immunecomplexes and variations of complement fractions in HBV, HDV and HCV infections: statistical analysis and clinical correlations. 35
Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis 35
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 35
Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C. 34
Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial. 34
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 34
[Effect of the administration of Cardiostenol on experimental hepatitis in mice induced with MHV-3 virus]. 33
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens 33
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 33
Epidemiology and Microbiology of Skin and Soft Tissue Infections: Preliminary Results of a National Registry 33
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 33
Immune system homeostasis during acute hepatitis C: viral escape or T-cell regulation? 32
Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C. 32
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. 32
Uno score non invasivo può predire la presenza di varici gastroesofagee nei pazienti con epatopatia cronica virale. 32
[Clinical and diagnostic considerations on a case of pancreatic plasmacytoma]. 32
Acute hepatitis C in patients undergoing hemodialysis: experience with high-dose interferon therapy 32
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 32
Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report 32
Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders 32
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 32
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naive for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 32
Prevalence of intranuclear particles in liver pathologies. 31
Sustained low influenza vaccination in health care workers after H1N1 pandemic: A cross sectional study in an Italian health care setting for at-risk patients 31
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 31
Contaminazione da HBsAg (antigene di superficie del virus epatitico B) in ambiente odontoiatrico 30
[Demonstration of the interchangeability of 2 types of recombinant anti-hepatitis-B vaccine]. 30
Prevalence of hepatitis C virus genotypes in southern Italy 30
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 30
Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet 30
Pernicious anemia during IFN-alpha treatment for chronic hepatitis C 29
Diffusione dell'infezione da virus epatitico B in ambiente odontoiatrico 29
Totale 4.099
Categoria #
all - tutte 33.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020304 0 0 0 0 47 5 3 6 6 43 114 80
2020/2021350 29 22 37 24 37 70 30 3 36 18 32 12
2021/20221.113 5 3 0 6 4 31 5 38 176 79 210 556
2022/20231.705 234 86 24 135 162 182 13 241 254 287 57 30
2023/2024950 35 160 217 40 35 64 19 85 9 16 165 105
2024/2025945 330 382 13 95 125 0 0 0 0 0 0 0
Totale 6.763